Assessment of mitotic rate reporting in melanoma

American Journal of Surgery

Volumn 204, Issue 6, 2012, Pages 969-975

  Burton, Alison L ^a   Egger, Michael E ^a   Gilbert, Juliana E ^a   Stromberg, Arnold J ^b   Hagendoorn, Lee ^c   Martin, Robert C G ^a   Scoggins, Charles R ^a   McMasters, Kelly M ^a   Callender, Glenda G ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Advertek Inc   (United States)

Author keywords

Melanoma; Mitotic rate; Prognosis

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CLINICAL ASSESSMENT; DATA BASE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MITOSIS; MITOSIS RATE; OVERALL SURVIVAL; PATHOLOGIST; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SKIN CANCER;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MITOTIC INDEX; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84871005007     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2012.05.021     Document Type: Article

References (14)

1. National Cancer Institute Surveillance Epidemiology and End Results http://seer.cancer.gov/statfacts/html/melan.html Accessed: March 7, 2012
2. National Cancer Institute melanoma factsheet http://www.cancer.gov/ cancertopics/types/melanoma Accessed: March 7, 2012
3. S.B. Kesmodel, G.C. Karakousis, J.D. Botbyl Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas Ann Surg Oncol 12 2005 449 458
4. P.A. Gimotty, D.E. Elder, D.L. Fraker Identification of high-risk patients among those diagnosed with thin cutaneous melanomas J Clin Oncol 25 2007 1129 1134
5. A.B. Francken, H.M. Shaw, J.F. Thompson The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up Ann Surg Oncol 11 2004 426 433
6. K.J. Busam The prognostic importance of tumor mitotic rate for patients with primary cutaneous melanoma Ann Surg Oncol 11 2004 360 361
7. S.B. Edge, D.R. Byrd, C.C. Compton AJCC Cancer Staging Manual 7th ed. 2009 Springer New York
8. J.E. Gershenwald, S.J. Soong, C.M. Balch TNM staging system for cutaneous melanoma...and beyond Ann Surg Oncol 17 2010 1475 1477
9. K.M. McMasters, D.S. Reintgen, M.I. Ross Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 8 2001 6
10. M.F. Azzola, H.M. Shaw, J.F. Thompson Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center Cancer 97 2003 1488 1498
11. V.K. Sondak, J.M. Taylor, M.S. Sabel Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model Ann Surg Oncol 11 2004 247 258
12. E. Zettersten, R.W. Sagebiel, J.R. Miller Prognostic factors in patients with thick cutaneous melanoma (> 4 mm) Cancer 94 2002 1049 1056
13. B.A. Roach, A.L. Burton, M.P. Mays Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma? Am J Surg 200 2010 759 764
14. K. Ikenberg, M. Pfaltz, C. Rakozy Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma J Cutan Pathol 39 2012 324 330